Quidel Corporation (QDEL) Social Stream



Quidel Corporation (QDEL): $82.14

0.83 (+1.02%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

QUIDELORTHO CORP (QDEL) Price Targets From Analysts

Use the tables below to see what analysts covering QUIDELORTHO CORP think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-05 2 $219 $155 $187 $79.73 134.54%
2022-02-22 3 $219 $130 $174.5 $79.73 118.86%
2022-05-05 2 $219 $136 $177.5 $79.73 122.63%
2022-06-17 3 $136 $110 $123 $79.73 54.27%
2022-08-04 4 $136 $86 $110.666 $79.73 38.8%
2022-08-09 4 $136 $86 $107.333 $79.73 34.62%

The Trend in the Analyst Price Target


Over the past 15 months, QDEL's average price target has gone down $65.42.

QDEL reports an average of 28.7% for its upside potential over the past 47 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-05 4 219 80 151.333 121.10 24.97%
2022-05-05 2 136 136 136.000 102.66 32.48%
2022-05-05 3 219 136 177.500 102.66 72.9%
2022-08-04 4 136 86 110.666 97.17 13.89%
2022-08-09 4 136 86 107.333 86.47 24.13%

QDEL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.5 2 0 1 1 1 4

The Trend in the Broker Recommendations


Over the past 61 days, QDEL's average broker recommendation rating worsened by 0.83.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for QDEL as an investment opportunity.

  • In the context of all US stocks, QUIDELORTHO CORP's number of analysts covering the stock is greater than 106.73% of them.
  • QDEL has a greater average analyst price target than 909.79% of Pharmaceutical Products stocks.
  • In terms of how QUIDELORTHO CORP fares relative to stocks in the large market cap category, note that its upside potential (average analyst target price relative to current price) is greater than 766.33% of that group.
  • QUIDELORTHO CORP's variance in analysts' estimates is lower than -206.98% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, NTLA, IDXX, and ZTS are the three stocks most similar to QUIDELORTHO CORP regarding the price target and analyst recommendation information presented here.

Is QDEL a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5288 seconds.